COVID-19 Vaccines and Ivermectin with MedCram and Dr. Roger Seheult

Long-haul COVID, or post-COVID syndrome, refers to persistent symptoms after an acute infection, including brain fog, heart problems, and lethargy. Surprisingly, it significantly affects younger individuals under 50, including teenagers and people in their 20s, even those who experienced mild initial symptoms and were not hospitalized.

Dr. Seheult explains that a death certificate lists the most proximal cause of death, followed by underlying conditions. If COVID-19 causes pneumonia and then acute respiratory distress syndrome, those complications should be listed, with COVID-19 inciting them. The CDC's statistic that only 5% of death certificates mention only COVID-19 does not mean COVID-19 wasn't the primary cause; rather, it often directly caused other listed conditions like pneumonia or respiratory failure.

Dr. Patrick clarifies that the spike protein in vaccines is structurally different from the SARS-CoV-2 viral spike protein. Vaccines contain a modified 'pre-fusion' spike protein that cannot elongate and fuse with cell membranes, unlike the viral version. Studies showing the danger of the viral spike protein do not apply to the vaccine's spike protein. Furthermore, natural infection exposes the body to thousands of viral spike proteins replicating throughout multiple organs, making the risk from infection much higher.

VAERS data must be interpreted carefully. Reporting requirements were expanded during the pandemic to include all serious adverse health events or deaths post-vaccination, even if causality is not suspected. Dr. Seheult demonstrates that the reported number of deaths in VAERS is significantly lower than the expected background death rate by chance alone for the vaccinated population, suggesting underreporting rather than a high rate of vaccine-related deaths. Scientists at the CDC and FDA analyze this data by stratifying it by age, gender, and ethnicity to identify genuine signals above background noise, as was done for myocarditis and blood clots.

It's human nature to connect proximate events, but medical decisions and public health policies must rely on epidemiological studies and statistics. While tragic individual cases can create hesitancy, broad conclusions require comparing reported events against expected background rates across large populations and ruling out confounding factors. Dr. Patrick points out that millions die daily from other causes unrelated to vaccines.

ADE occurs when antibodies bind to a virus but fail to neutralize it, instead enhancing the infection and causing more severe disease. This was a concern with an RSV vaccine in the 1960s. However, current COVID-19 vaccines are designed using a 'pre-fusion' spike protein, preventing the formation of 'post-fusion' antibodies linked to ADE. Real-world data from countries like Israel show unvaccinated individuals consistently have more severe COVID-19 cases, directly refuting ADE in vaccinated populations.

No, current data suggests COVID-19 vaccines do not negatively impact fertility or pregnancy outcomes. Phase three trials showed no significant differences in pregnancies or miscarriages between vaccinated and control groups. Follow-up studies, including one in the New England Journal of Medicine, confirmed miscarriage rates within the normal range. Studies have also found no effect on embryo implantation or male sperm parameters.

No, mRNA vaccines are not gene therapy and do not alter our DNA. Dr. Patrick explains that DNA resides in the cell's nucleus, protected by a nuclear membrane. mRNA, lacking a nuclear localization sequence, cannot enter the nucleus. Additionally, it would need reverse transcriptase to become DNA and integrase to incorporate into our genome, neither of which are present from the vaccine. It's a protein-making technology, not a DNA-altering one.

No, the available high-quality evidence does not support Ivermectin as a replacement for vaccines. While some in vitro studies showed efficacy at very high concentrations, human dosing results in much lower levels. Meta-analyses have shown moderate certainty for reduced death but low certainty for other benefits, often complicated by co-treatments and high parasitic infection rates in study populations. Sensationalizing Ivermectin's benefits without robust randomized controlled trials is misleading and dangerous, especially as it encourages unapproved veterinary forms.

Vaccines still reduce overall transmission by preventing a percentage of infections. While initial viral loads in breakthrough infections can be similar to unvaccinated individuals, vaccinated people clear the virus faster. Real-time data shows vaccinated individuals have lower viral loads at any given time and are less likely to infect others. Therefore, vaccines reduce both overall and onward transmission, although efficacy against infection has decreased with the Delta variant compared to earlier strains.

The selective pressure on viruses is primarily to become more transmissible, not more virulent (deadly). Although virulence can incidentally increase with transmissibility, viruses generally don't benefit from killing their hosts quickly. Unvaccinated individuals, who allow greater viral replication for longer periods, contribute more to the potential for new variants to emerge. There is no evidence of human vaccines causing more virulent strains; vaccine 'escape immunity' is a different phenomenon where variants evade vaccine-induced antibodies.

The process was accelerated but not rushed in terms of scientific rigor. Key steps like phase 1, 2, and 3 trials were not skipped but were run concurrently. Governments provided significant funding to remove financial risks for companies, allowing them to build manufacturing facilities while trials were ongoing. This mirrored wartime production efforts. Furthermore, mRNA technology is not new; it has been researched and clinically tested in humans for over 20 years for various applications, including other infectious diseases and cancer immunotherapy.

Yes. While the Delta variant has reduced vaccine efficacy in preventing infections, vaccines are still highly effective at preventing hospitalization and severe disease. Data from the UK's third (Delta) wave clearly shows a decoupling of infection rates from death rates compared to previous waves where vaccines were not widespread. This indicates vaccines are still holding up well in preventing the most severe outcomes, although some waning efficacy in the elderly or those vaccinated longest may necessitate boosters.